Funding round · 2026-11-10 · Healthcare
Efferon raises $4.6M
Efferon has raised €4.3 million from existing private investors in the DACH region to expand its hemoadsorption devices beyond critical care into healthy aging applications. The funding will support commercial expansion of Efferon LPS and Efferon NEO in Europe, India, and Latin America, plus its 21-distributor network and regulatory work. Efferon devices are used in 46 countries with over 30,000 treatments performed, and the company reported revenue above €1.1 million in 2025.
- Participants:
- —
- Source:
- Tech.eu ↗ · Midu summary
Deal Dossier PRO
Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.
Generate dossier — ProFigures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).
Recent Healthcare rounds
Subscribe to the newsletters
Free, by email. No account needed. Pick one or both.
No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.
Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing